Warning Letter — Fil-Bay Import, Inc.
The FDA issued a Warning Letter to Fil-Bay Import, Inc. following an inspection by the Office of Inspections and Investigations. The letter details compliance failures identified at the firm's facility.
This affects Fil-Bay Import, Inc., as well as personnel responsible for import compliance, quality assurance, and supply chain oversight for imported food products.
The issuance of a Warning Letter from the Office of Inspections and Investigations indicates that the firm's initial responses to inspectional observations were likely insufficient to address regulatory concerns. This action suggests a heightened risk of enforcement, such as import alerts or seizures, if the noted deficiencies are not corrected. While the source does not detail the specific violations, such letters typically involve failures in maintaining required safety standards or documentation for imported goods.
Regulatory and QA teams should review their supplier verification programs and ensure all imported products meet specific FDA safety and labeling requirements. Immediate internal audits of current inventory against federal standards are advisable to prevent detention of goods.
FDA Warning Letter issued to: Fil-Bay Import, Inc.. 07/20/2026 — Office of Inspections and Investigations. Source: https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/fil-bay-import-inc-734615-07202026
Open in openFDA / FDA.gov